Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cloud-Clone
Katy, Texas, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Cloud-Clone does not develop therapeutics; instead, it is a commercial supplier of high-quality reagents (proteins, antibodies, assay kits) cited in over 24,000 published research articles, with products widely used for biomarker and drug target detection in academic and industry research, including disease-focused ELISA kits.[3][4][5]
- Therapeutic areas
- CardiovascularImmunologyRheumatologyWomen's HealthInfectious DiseasesNeurologyPulmonologyMetabolic DisordersGastroenterologyOtherOncology
- Modalities
- Recombinant proteinPolyclonal antibodyMonoclonal antibodyRecombinant antibodySmall moleculeSynthetic peptideAssay kitCell product
- Industry
- Protein Biomarker Diagnostics
Beyond the preview
Go deeper on Cloud-Clone.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cloud-Clone.